You are here: Industry Insights > COVID-19 vaccine

News List

Dutch Intravacc to in-license CimCure’s iBoost technology, expands its vaccine platform portfolio expresspharma
July 02, 2020
The iBoost (immune boost) technology was developed at Amsterdam UMC, lab-location VUMC, by Prof. Dr. Arjan Griffioen, professor of experimental oncology and CSO at CimCure.
How glass vial makers are girding to boost access to COVID-19 vaccine expresspharma
July 02, 2020
Leading glass packaging manufacturers in India disclose their measures to ramp up capacities and support India Pharma Inc as it prepares to aid global inoculation against COVID-19.
Pfizer, BioNTech post positive data from study of COVID-19 vaccine candidate expresspharma
July 02, 2020
If studies are successful and mRNA-based vaccine candidate receives regulatory approval, companies expect to manufacture up to 100 million doses by the end of 2020 and potentially more than 1.2 billion doses by the end of 2021.
FDA Takes Action to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines worldpharmanews
July 01, 2020
The U.S. Food and Drug Administration took important action to help facilitate the timely development of safe and effective vaccines to prevent COVID-19 by providing guidance with recommendations for those developing COVID-19 vaccines ...
First COVID-19 vaccine clinical trial approved in India europeanpharmaceuticalreview
July 01, 2020
Indian authorities have given the green light to test Bharat Biotech’s COVID-19 vaccine in Phase I and Phase II clinical trials.
Imperial COVID-19 vaccine begins human testing pharmatimes
June 30, 2020
Imperial College London's experimental COVID-19 vaccine has been given to the first healthy volunteer at a facility in West London.
Brazil signs $127m deal to manufacture Oxford Covid-19 vaccine pharmaceutical-technology
June 30, 2020
Brazil has entered an agreement worth $127m to manufacture a Covid-19 vaccine candidate which was developed by the University of Oxford and licensed to AstraZeneca.
GSK COVID-19 vaccine development collaboration with Clover Biopharmaceuticals begins clinical trials worldpharmanews
June 29, 2020
GSK's scientific collaboration with Clover Pharmaceuticals to develop an adjuvanted COVID-19 vaccine has entered into human clinical trials.
Brazil signs agreement to produce AstraZeneca’s COVID-19 vaccine candidate expresspharma
June 29, 2020
Brazil has signed a $127 million agreement to start producing locally an experimental vaccine developed by AstraZeneca that has shown promise to fight the COVID-19 pandemic.
Consortium established to monitor COVID-19 vaccines after marketing europeanpharmaceuticalreview
June 28, 2020
A new consortium has been formed for the study of COVID-19 vaccines after their approval, to monitor their safety and efficacy.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page